A QSAR study on influenza neuraminidase inhibitors.

Influenza is a major respiratory infection associated with significant morbidity in the general population and mortality in elderly and high-risk patients. It is an RNA virus that contains two major surface glycoproteins, neuraminidase and hemagglutinin. These proteins are essential for infection. Neuraminidase has been found to be a potential target to control influenza virus. In this paper, we have developed 17 quantitative structure-activity relationships (QSAR) for different sets of compounds to understand chemical-biological interactions governing their activities toward influenza neuraminidase.

[1]  G. Air,et al.  Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. , 1999, Journal of medicinal chemistry.

[2]  W G Laver,et al.  Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores. , 2001, Journal of medicinal chemistry.

[3]  R. Verma.  Understanding topoisomerase I and II in terms of QSAR. , 2005, Bioorganic & medicinal chemistry.

[4]  C. Hansch,et al.  On the role of polarizability in QSAR. , 2005, Bioorganic & medicinal chemistry.

[5]  Corwin Hansch,et al.  The role of QSAR in dopamine interactions. , 2005, Bioorganic & medicinal chemistry letters.

[6]  W G Laver,et al.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. , 1997, Journal of the American Chemical Society.

[7]  Corwin Hansch,et al.  On the Role of Polarizability in Chemical-Biological Interactions , 2003, J. Chem. Inf. Comput. Sci..

[8]  M. Tute,et al.  The inhibition of viral neuraminidase by 1-phenoxymethyl-3,4-dihydroisoquinolines. II. A Hansch analysis. , 1970, Journal of medicinal chemistry.

[9]  R. Verma.  An Approach Towards the Quantitative Structure-Activity Relationships for Sulfamate-Based Estrone Sulfatase Inhibitors , 2005 .

[10]  Searching for allosteric effects via QSARs. , 2001, Bioorganic & medicinal chemistry.

[11]  A J Elliott,et al.  Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity. , 2001, Journal of medicinal chemistry.

[12]  Raymond C. Stevens,et al.  Structure-activity relationships of carbocyclic influenza neuraminidase inhibitors , 1997 .

[13]  Zongru Guo,et al.  Study on molecular mechanism and 3D-QSAR of influenza neuraminidase inhibitors. , 2003, Bioorganic & medicinal chemistry.

[14]  Ali Dehghani,et al.  Syntheses and neuraminidase inhibitory activity of multisubstituted cyclopentane amide derivatives. , 2004, Journal of medicinal chemistry.

[15]  M. Abraham,et al.  The use of characteristic volumes to measure cavity terms in reversed phase liquid chromatography , 1987 .

[16]  A J Elliott,et al.  BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. , 2000, Journal of medicinal chemistry.

[17]  C. Hansch,et al.  Allosteric interactions and QSAR: on the role of ligand hydrophobicity. , 2003, Bioorganic & medicinal chemistry.

[18]  C. Hansch,et al.  Comparative Quantitative Structure−Activity Relationship Studies on Anti-HIV Drugs , 1999 .

[19]  C. Hansch,et al.  The role of hydrophobic properties of chemicals in promoting allosteric reactions. , 2005, Bioorganic & medicinal chemistry.

[20]  A. Leo,et al.  Chem-bioinformatics: comparative QSAR at the interface between chemistry and biology. , 2002, Chemical reviews.

[21]  R. Compans,et al.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. , 1974, Virology.

[22]  W G Laver,et al.  Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. , 1998, Journal of medicinal chemistry.

[23]  W G Laver,et al.  A new series of C3-aza carbocyclic influenza neuraminidase inhibitors: synthesis and inhibitory activity. , 1998, Bioorganic & medicinal chemistry letters.

[24]  D. M. Ryan,et al.  Rational design of potent sialidase-based inhibitors of influenza virus replication , 1993, Nature.

[25]  C. Hansch,et al.  A comparison between two polarizability parameters in chemical--biological interactions. , 2005, Bioorganic & medicinal chemistry.

[26]  Corwin Hansch,et al.  An approach toward the problem of outliers in QSAR. , 2005, Bioorganic & medicinal chemistry.